Mucosal modulation by LGG and R. gnavus specific tryptophan metabolites
LGG 和 R. gnavus 特异性色氨酸代谢物对粘膜的调节
基本信息
- 批准号:9788244
- 负责人:
- 金额:$ 38.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-20 至 2022-08-31
- 项目状态:已结题
- 来源:
- 关键词:16S ribosomal RNA sequencingARNT geneAblationAcuteAddressAffectAffinityAgonistAnimal ModelAnti-inflammatoryAryl Hydrocarbon ReceptorBacteriaBindingBiologicalBiological AssayCell CompartmentationCell NucleusCell physiologyColitisCollaborationsDataDietDiseaseElementsEngineeringEpithelialEpithelial CellsEssential Amino AcidsExcisionGene ExpressionGenesGeneticGerm-FreeGnotobioticHealthHomeostasisImmuneImpairmentInflammatory disease of the intestineInnate Immune ResponseInterventionIntestinal MucosaIntestinesKnock-outKnockout MiceLactobacillusLactobacillus casei rhamnosusLamina PropriaLigandsLinkLiteratureMammalsMediatingMucolyticsMucosal Immune ResponsesMucous MembraneMusNatureOrganoidsPathway interactionsPerfusionPhysiologyPlayPredispositionProbioticsPropertyProtein BiosynthesisPublic HealthReceptor ActivationReceptor SignalingRecording of previous eventsRoleSignal PathwaySignal TransductionSourceStructureSystemTestingTight JunctionsTryptaminesTryptophanWorkaryl hydrocarbon receptor ligandbacterial geneticsbeta catenincytokinedietary manipulationdimerdysbiosisexperiencehigh riskhost-microbe interactionsinnovationmetabolomicsmicrobialmicrobial communitymicrobiotamouse modelmutantpathobiontpromoterreceptor structure functionscreeningstem cell divisiontranscriptome sequencing
项目摘要
PROJECT SUMMARY:
The dietary benefits of tryptophan have been classically linked to its property as an essential amino acid required
by mammals for protein synthesis, but recent work in the past decade has revealed its equally essential role as
an important source of metabolites for the microbial community to generate signals, mainly via the Aryl
Hydrocarbon Receptor (AHR), to affect a plethora of cellular functions. AHR signaling pathway is highly
promiscuous not only responding to diverse ligands with resembling structures, but also crosstalk with and is
modulated by numerous cellular signaling pathways. Distinct agonists can result in ligand selective differences
in AHR structure and function, ultimately leading to agonist-selective gene expression and biological effects. In
the gut, AHR activation by bacterial tryptophan catabolites influences mucosal homeostasis and microbiota
composition. Although bacterial tryptophan metabolites and AHR axis may contribute to microbial sensing and
tolerance, it is unclear if probiotics and pathobionts produce distinct tryptophan metabolites thereby eliciting
bacterial species- and agonist-specific host mucosal modulating effects. Both Lactobacillus and Ruminoccocus
spp catabolize tryptophan to a variety of tryptamine and indolic products that bind at low to high affinities to the
AHR. The identities and specific biological effects of tryptophan metabolites produced by the probiotic
Lactobacillus rhamnosus GG (LGG) and the pathobiont R. gnavus are currently unknown. Preliminary RNA-Seq
analysis of mouse intestinal mucosa perfused with live LGG revealed a robust induction of AHR signaling activity
as well as anti-inflammatory cytokines. Bacterial 16s rRNA sequencing and untargeted fecal metabolomics
screening of a newly engineered Lyz1 knockout mouse model revealed a dysbiosis featured by expansion of
mucolytic bacterial species (e.g., R. gnavus), accompanied by a pronounced elevation of tryptophan metabolites
and a changed epithelial cell composition. The hypothesis is that the probiotic LGG and the pathobiont R. gnavus
metabolize dietary tryptophan into distinct agonists that elicit differential mucosal modulating effects via the host
AHR signaling. Aim I will use mono-colonization of germ-free mice, dietary tryptophan depletion, unbiased
metabolomics profiling, and isogenic mutant bacteria deficient in tryptophan-metabolizing to identify LGG and R.
gnavus specific tryptophan metabolites and their differential mucosal modulating effects. Aim 2 will employ
organoid culture, intraluminal perfusion of AHR agonists, and genetic ablation of host AHR signaling to determine
the direct effects of bacterial species-specific tryptophan metabolites and AHR signaling on Lyz1-deficient mouse
mucosal homeostasis and colitis susceptibility. This MPI project uses rigorous approaches, including
gnotobiotics, bacterial genetics, dietary manipulation, and unbiased metabolomics, etc. to address an important
mechanism involving diet-microbe-host interaction that may underlie the biological natures of probiotics and
pathobionts. The two PIs have a history of productive collaboration, and have demonstrated experiences in
studying intestinal physiology. This project employing innovative animal models is significant for public health
and disease intervention.
项目摘要:
色氨酸的饮食益处经典地与其特性联系在一起,作为必需的氨基酸
通过哺乳动物进行蛋白质合成,但在过去十年中最近的工作揭示了其同样重要的作用
微生物群落生成信号的代谢产物的重要来源,主要通过芳基
碳氢化合物受体(AHR),以影响大量细胞功能。 AHR信号通路高度高
混杂的不仅与结构相似的不同配体做出反应,而且还与
由许多细胞信号通路调节。不同的激动剂会导致配体选择性差异
在AHR结构和功能中,最终导致了激动剂选择性基因表达和生物学作用。在
细菌色氨酸分解代谢物的肠道激活会影响粘膜稳态和微生物群
作品。尽管细菌色氨酸代谢产物和AHR轴可能有助于微生物感应和
耐受性,尚不清楚益生菌和病原体是否产生不同的色氨酸代谢产物,从而引起
细菌种类和激动剂特异性宿主粘膜调节作用。乳酸杆菌和蔬菜菌
SPP将色氨酸分解为各种色氨酸和吲哚胺的产品,它们以低至高亲和力结合到高亲和力
啊。益生菌产生的色氨酸代谢产物的身份和特定生物学作用
目前尚不清楚rhamnosus lamnosus gg(LGG)和Pathobiont R. gnavus。初步RNA-Seq
用实时LGG灌注的小鼠肠粘膜分析显示AHR信号传导活性的强烈诱导
以及抗炎细胞因子。细菌16S rRNA测序和未靶向的粪便代谢组学
筛选新设计的LYZ1敲除鼠标模型显示出一种营养不良的膨胀。
粘液溶解细菌种(例如,gnavus),伴随着色氨酸代谢物的明显升高
以及改变的上皮细胞组成。假设是益生菌LGG和Pathobiont R. gnavus
将饮食色氨酸代谢成不同的激动剂,这些激动剂会通过宿主引起差异粘膜调节作用
AHR信号。目的我将使用无细菌小鼠的单色殖民化,饮食色氨酸耗竭,无偏见
代谢组学分析和异源性突变细菌缺乏色氨酸量代谢,以鉴定LGG和R。
特异性色氨酸代谢产物及其差异粘膜调节作用。 AIM 2将使用
器官培养,AHR激动剂的腔内灌注以及宿主AHR信号的遗传消融以确定
细菌特异性色氨酸代谢产物和AHR信号对LYZ1缺陷小鼠的直接影响
粘膜稳态和结肠炎的敏感性。该MPI项目使用严格的方法,包括
gnotobiotics,细菌遗传学,饮食操纵和无偏的代谢组学等,以解决重要的
涉及饮食 - 微生物宿主相互作用的机制,可能是益生菌和
Pathobionts。这两个PI有生产性合作的历史,并展示了
研究肠道生理学。这个采用创新动物模型的项目对公共卫生非常重要
和疾病干预。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RONALDO PARAOAN FERRARIS其他文献
RONALDO PARAOAN FERRARIS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RONALDO PARAOAN FERRARIS', 18)}}的其他基金
Regulation of intestinal phosphate uptake by dietary carbohydrate
膳食碳水化合物对肠道磷酸盐吸收的调节
- 批准号:
7255939 - 财政年份:2007
- 资助金额:
$ 38.75万 - 项目类别:
Regulation of intestinal phosphate uptake by dietary carbohydrate
膳食碳水化合物对肠道磷酸盐吸收的调节
- 批准号:
7392327 - 财政年份:2007
- 资助金额:
$ 38.75万 - 项目类别:
DIETARY REGULATION OF NUTRIENT ABSORPTION IN AGING
衰老过程中营养吸收的饮食调节
- 批准号:
2052594 - 财政年份:1994
- 资助金额:
$ 38.75万 - 项目类别:
DIETARY REGULATION OF NUTRIENT ABSORPTION IN AGING
衰老过程中营养吸收的饮食调节
- 批准号:
2667621 - 财政年份:1994
- 资助金额:
$ 38.75万 - 项目类别:
DIETARY REGULATION OF NUTRIENT ABSORPTION IN AGING
衰老过程中营养吸收的饮食调节
- 批准号:
2376192 - 财政年份:1994
- 资助金额:
$ 38.75万 - 项目类别:
DIETARY REGULATION OF NUTRIENT ABSORPTION IN AGING
衰老过程中营养吸收的饮食调节
- 批准号:
2052595 - 财政年份:1994
- 资助金额:
$ 38.75万 - 项目类别:
DIETARY REGULATION OF NUTRIENT ABSORPTION IN AGING
衰老过程中营养吸收的饮食调节
- 批准号:
2052597 - 财政年份:1994
- 资助金额:
$ 38.75万 - 项目类别:
DIETARY REGULATION OF NUTRIENT ABSORPTION IN AGING
衰老过程中营养吸收的饮食调节
- 批准号:
2052596 - 财政年份:1994
- 资助金额:
$ 38.75万 - 项目类别:
相似海外基金
Neural mechanisms underlying circadian rhythms in behavior
行为昼夜节律的神经机制
- 批准号:
9258619 - 财政年份:2017
- 资助金额:
$ 38.75万 - 项目类别:
Signaling Mechanisms of TCDD-induced AHR Activation
TCDD 诱导 AHR 激活的信号机制
- 批准号:
7263897 - 财政年份:2003
- 资助金额:
$ 38.75万 - 项目类别:
HIF- 2ALPHA, Hypoxic Gene Regulation, and Angiogenesis
HIF-2ALPHA、缺氧基因调节和血管生成
- 批准号:
8286244 - 财政年份:2000
- 资助金额:
$ 38.75万 - 项目类别:
Combined HIF deficiency in inflammation-associated colorectal tumorigenesis
炎症相关结直肠肿瘤发生中联合 HIF 缺乏
- 批准号:
8838847 - 财政年份:2000
- 资助金额:
$ 38.75万 - 项目类别: